OpenVSafe by OpenVAERS
Search V-safe

5PQ-18493-52149

3 vaccinations 10 coded responses 35 check-ins 10 free-text entries 2 call cases
Sex
Male
Age at first dose
36-40
ZIP prefix
787 / TX
Registered
2021-04-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-22
    Registered in v-safe
  2. 2021-04-22
    Dose 1 — Moderna
  3. 2021-04-22
    Survey response — day 0, dose 1
    MedDRA: Disorientation, Flushing — Feeling: Fair · Headache
    Free text: Flushed feeling and mild disorientation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Nausea
    Adult check-in
  5. 2021-04-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Swelling · None
    Adult check-in
  6. 2021-04-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-04-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-04-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-29
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-05-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-05-13
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-05-20
    Dose 2 — Moderna
  13. 2021-05-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Office visit — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Psychotherapy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-22
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-05-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2021-05-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness
    Adult check-in
  17. 2021-05-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  18. 2021-05-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  19. 2021-05-27
    Health check-in — day 7, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  20. 2021-06-03
    Survey response — day 14, dose 2
    MedDRA: Chest pain, Dyspnoea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Chest pains, difficulty breathing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-06-10
    Survey response — day 21, dose 2
    MedDRA: Depression, Dyspnoea, Gastrooesophageal reflux disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Depression, acid reflux, difficulty breathing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-06-17
    Survey response — day 28, dose 2
    MedDRA: Obsessive-compulsive disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Compulsive behavior
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-06-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-08-19
    Survey response — 3 months, dose 2
    MedDRA: Arthralgia, Ear pain, Erythema, Headache, Myalgia, Oropharyngeal pain, Paranasal sinus hypersecretion, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Multiple fevers, extreme apex headache, muscle and joint pain, ear pain and redness, mild sore throat and sinus drainage
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-11-17
    Dose 3 — Moderna
  27. 2021-11-18
    Survey response — 6 months, dose 2
    MedDRA: Arthralgia, Frustration tolerance decreased, Patellofemoral pain syndrome, Pre-existing disease, Pyrexia — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Autistic frustration increased. Fever. Aches in joints. Level 4 chondromalacia in right knee.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-11-18
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  29. 2021-11-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  30. 2021-11-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  31. 2021-11-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Joint pains, Fatigue or tiredness
    Adult check-in
  32. 2021-11-22
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  33. 2021-11-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-11-24
    Health check-in — day 7, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  35. 2021-12-01
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-12-08
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-12-15
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-12-22
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-12-29
    Survey response — day 42, dose 3
    MedDRA: Corneal dystrophy, Depression — Feeling: Good · Be unable to do your normal daily activities
    Free text: Depression, Map Dot Fingerprint Corneal Dystrophy
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-02-16
    Survey response — 3 months, dose 3
    MedDRA: Gastritis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Gastritis and possible pancreatitis
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-05-20
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-11-17
    Survey response — 12 months, dose 3
    MedDRA: Aphasia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Temporary loss of speech
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-22Moderna
22021-05-20Moderna
32021-11-17Moderna No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 7 — day 0, dose 1

2021-04-22

Systemic reaction (other): Flushed feeling and mild disorientation

Release 8 — days 1–6 daily, dose 2

2021-05-22

Healthcare visit (other): Psychotherapy

Release 8 — day 14, dose 2

2021-06-03

Symptoms: Chest pains, difficulty breathing

Release 9 — day 21, dose 2

2021-06-10

Symptoms: Depression, acid reflux, difficulty breathing

Release 9 — day 28, dose 2

2021-06-17

Symptoms: Compulsive behavior

Release 9 — 3 months, dose 2

2021-08-19

Symptoms: Multiple fevers, extreme apex headache, muscle and joint pain, ear pain and redness, mild sore throat and sinus drainage

Release 10 — 6 months, dose 2

2021-11-18

Symptoms: Autistic frustration increased. Fever. Aches in joints. Level 4 chondromalacia in right knee.

Release 10 — day 42, dose 3

2021-12-29

Symptoms: Depression, Map Dot Fingerprint Corneal Dystrophy

Release 11 — 3 months, dose 3

2022-02-16

Symptoms: Gastritis and possible pancreatitis

Release 12 — 12 months, dose 3

2022-11-17

Symptoms: Temporary loss of speech

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDAphasia · · ✓
SDArthralgia ✓ · ✓
SDChest pain ✓ ✓ ✓
SDCorneal dystrophy · · ✓
SDDepression ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDEar pain ✓ · ✓
SDErythema ✓ · ✓
SDFrustration tolerance decreased · · ✓
SDGastritis · · ✓
SDGastrooesophageal reflux disease ✓ ✓ ✓
SDHeadache ✓ · ✓
SDMyalgia ✓ · ✓
SDObsessive-compulsive disorder ✓ ✓ ✓
SDOropharyngeal pain ✓ · ✓
SDParanasal sinus hypersecretion ✓ · ✓
SDPatellofemoral pain syndrome · · ✓
SDPre-existing disease · · ✓
SDPyrexia ✓ · ✓
SRODisorientation ✓ ✓ ✓
SROFlushing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release